recall
saveAEQUITA PHARMACY recall (Cls II)
August 13, 2025updated 5mo ago
community read0 votes
Tirzepatide + Niacinamide 4.4 mg + 1.0mg/0.5 mL Inj Sol, Inject 0.5 mL (50 units on syringe) subcutaneously, Sterile, 2 mL Multi Dose Vial, Refrigerate, Do not freeze, Aequita Pharmacy LLC, Kirkland, WA 98034. — Reason: Lack of Processing Controls. — Status: Ongoing
view source ↗Data sources
last refreshed 3m ago
Found something off?
same company · ±60 days · 6
- recallAEQUITA PHARMACY recall (Cls II)Aug 13, 2025
- recallAEQUITA PHARMACY recall (Cls II)Aug 13, 2025
- recallAEQUITA PHARMACY recall (Cls II)Aug 13, 2025
- recallAEQUITA PHARMACY recall (Cls II)Aug 13, 2025
- recallAEQUITA PHARMACY recall (Cls II)Aug 13, 2025
- recallAEQUITA PHARMACY recall (Cls II)Aug 13, 2025
🐶 often sniffed alongside
top 8- tagApproval150 co-mentions · 75 sources
- drugMOUNJARO48 co-mentions · 24 sources
- drugZEPBOUND48 co-mentions · 24 sources
- drugtirzepatide48 co-mentions · 24 sources
- drugTRULICITY44 co-mentions · 22 sources
- drugdulaglutide44 co-mentions · 22 sources
- drugselpercatinib38 co-mentions · 19 sources
- drugRETEVMO38 co-mentions · 19 sources
comments(0)
5-min edit window · permanent after that